HSPG2 and glomerular disorder: Surprisingly, despite the proven functionality of the hM3D receptor in podocytes as demonstrated in vitro, ex vivo and in vivo, activation of the PLC pathway did not affect glomerular filtration or perfusion nor caused glomerular disease even after a prolonged stimulation for 18 consecutive days.